1. Home
  2. LENZ

as of 02-17-2026 4:00pm EST

$13.04
+$0.16
+1.24%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Founded: 2019 Country:
United States
United States
Employees: N/A City: SOLANA BEACH
Market Cap: 609.5M IPO Year: 2021
Target Price: $56.25 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.11 EPS Growth: N/A
52 Week Low/High: $12.48 - $50.40 Next Earning Date: 03-18-2026
Revenue: $17,500,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 194.79%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -46161000.0 FCF Growth: N/A

AI-Powered LENZ Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 71.64%
71.64%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: